Atul Pande, M.D., is Chief Medical Officer of Tal Medical, and former President of Verity BioConsulting, LLC. Dr. Pande was formerly the Senior Vice President, Neurosciences Medicines Development Center at GlaxoSmithKline. Dr. Pande received his medical training in India and trained in psychiatry in India and subsequently at the University of Western Ontario in London, Canada. Following a mood disorders research fellowship at the University of Michigan Medical School, Dr. Pande served on the Department of Psychiatry faculty. In 1992, Dr. Pande joined the Lilly Research Laboratories in Indianapolis. Since then he has continued his career in pharmaceutical research and has held positions at Parke-Davis Pharmaceutical Research (now part of Pfizer), Pfizer Global R&D and Cenerx Biopharma. Dr. Pande has drug development and regulatory submission experience in in a broad range of psychiatric and neurological disorders. Dr. Pande has over 50 peer-reviewed publications, 6 patents, and numerous book chapters, abstracts and scientific presentations to his credit. Dr. Pande is a member of the Society of Biological Psychiatry, and a Fellow of the Royal College of Physicians and Surgeons of Canada, the American Psychiatric Association, the Canadian College of Neuropsychophramcology and the Collegium Internationale Neuro-Psychopharmacologicum.